Related Experiment Videos
Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium
Sachiko Matsuzaki1, Michel Canis, Jean-Luc Pouly
1Department of Gynecology, Hôtel-Dieu, Polyclinique, CHU, Clermont-Ferrand, France. sachikoma@aol.com
Fertility and Sterility
|November 10, 2004
Summary
Cyclooxygenase-2 (Cox-2) expression is elevated in the endometrium of women with deep endometriosis. This increased Cox-2 expression correlates with more severe endometriosis-related dysmenorrhea, suggesting a role in pain.
Area of Science:
- Reproductive medicine and molecular biology.
- Pain research and endometriosis studies.
Background:
- Endometriosis is a condition characterized by endometrial tissue outside the uterus.
- Dysmenorrhea, or painful menstruation, is a common and often severe symptom of endometriosis.
- Cyclooxygenase-2 (Cox-2) is an enzyme implicated in inflammation and pain.
Purpose of the Study:
- To investigate the association between cyclooxygenase-2 (Cox-2) expression levels and the severity of endometriosis-related dysmenorrhea.
- To determine if Cox-2 expression differs in eutopic endometrium from women with deep endometriosis compared to controls.
Main Methods:
- A prospective study was conducted at a university hospital.
- Tissue samples of deep endometriosis and eutopic endometrium were collected from 46 patients with deep endometriosis.
- Control endometrial tissue was obtained from 34 women undergoing tubal ligation; pain was assessed using a 10-point linear analogue scale.
Main Results:
- Cox-2 expression was significantly higher in eutopic endometrial stromal cells of patients with deep endometriosis compared to controls across secretory phases.
- In endometriosis patients, higher Cox-2 expression in eutopic endometrial stromal cells was linked to more severe dysmenorrhea (pain score ≥7).
Conclusions:
- Elevated Cox-2 expression in eutopic endometrial stromal cells of women with deep endometriosis may contribute to severe dysmenorrhea.
- These findings suggest Cox-2 as a potential therapeutic target for endometriosis-associated pain.